(Q42360535)

28 October 2017

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid-directed monoclonal antibody (English)

1 reference

28 October 2017

1 reference

1

Morie A Gertz

1 reference

28 October 2017

Heather J Landau

2

1 reference

PMCID

5132098

28 October 2017

Brendan M Weiss

series ordinal

3

1 reference

PMCID

5132098

28 October 2017

language of work or name

1 reference

20 September 2016

1 reference

American Journal of Hematology

28 October 2017

1 reference

28 October 2017

91

1 reference

28 October 2017

12

1 reference

28 October 2017

E506-E508

1 reference

Beyond the plasma cell: emerging therapies for immunoglobulin light chain amyloidosis

28 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132098

First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132098

Immunoglobulin light chain amyloidosis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132098

Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5132098

A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

29 May 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FAJH.24563

21 January 2018

Identifiers

DOI

10.1002/AJH.24563

1 reference

28 October 2017

1 reference

28 October 2017

1 reference

PMCID

5132098